Secondary amenorrhea and anovulatory infertility can result from various distinct pathophysiologic processes affecting the hypothalamic-pituitary-ovarian (HPO) axis. Match each patient's clinical presentation with its most characteristic serum endocrine laboratory profile.
- A 22-year-old competitive cross-country runner with a body mass index of 17 kg/m²Decreased FSH, decreased LH, and decreased estradiol
- A 33-year-old with severe hot flashes, vaginal dryness, and a history of FMR1 gene premutationSignificantly elevated FSH, elevated LH, and decreased estradiol
- A 28-year-old with worsening facial acne, hirsutism, and a body mass index of 32 kg/m²Normal to elevated LH, normal FSH, and normal estradiol
- A 30-year-old with persistent bilateral galactorrhea and intermittent headachesMarkedly elevated prolactin with secondary decreases in FSH, LH, and estradiol
Answer
The competitive runner matches with decreased FSH, LH, and estradiol (functional hypothalamic amenorrhea). The patient with the FMR1 premutation matches with elevated FSH/LH and decreased estradiol (primary ovarian insufficiency). The patient with hirsutism matches with normal/elevated LH and normal estradiol (polycystic ovary syndrome). The patient with galactorrhea matches with elevated prolactin and suppressed gonadotropins (prolactinoma).
Each condition affects the hypothalamic-pituitary-ovarian axis uniquely: functional hypothalamic amenorrhea suppresses central GnRH (leading to low FSH, LH, and estradiol); primary ovarian insufficiency represents primary end-organ failure without central negative feedback (leading to high FSH, high LH, and low estradiol); polycystic ovary syndrome is a normogonadotropic state with altered pulsatility (leading to high/normal LH, normal FSH, and normal estradiol); and prolactinomas suppress GnRH via elevated prolactin levels.
Step-by-Step Solution
Key Concept
Endocrine evaluation of secondary amenorrhea and infertility localizes the physiological defect to the hypothalamus, pituitary, or ovaries based on the pattern of FSH, LH, and estradiol levels.